Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease

Authors: K Sopova, D Delialis, E Aivalioti, S Athanasopoulos, G Georgiopoulos, S Stamatelopoulos, K Stellos

Published: 2024-05-29

DOI: 10.1093/cvr/cvae088.077

Source: Full article